Annual Total Debt
$28.62 B
-$610.00 M-2.09%
31 December 2023
Summary:
AstraZeneca annual total debt is currently $28.62 billion, with the most recent change of -$610.00 million (-2.09%) on 31 December 2023. During the last 3 years, it has risen by +$8.24 billion (+40.44%). AZN annual total debt is now -7.01% below its all-time high of $30.78 billion, reached on 31 December 2021.AZN Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Debt
$31.56 B
-$1.97 B-5.88%
30 September 2024
Summary:
AstraZeneca quarterly total debt is currently $31.56 billion, with the most recent change of -$1.97 billion (-5.88%) on 30 September 2024. Over the past year, it has increased by +$2.99 billion (+10.45%). AZN quarterly total debt is now -8.65% below its all-time high of $34.55 billion, reached on 31 March 2024.AZN Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AZN Total Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2.1% | +10.4% |
| 3 y3 years | +40.4% | -1.1% |
| 5 y5 years | +49.8% | +73.8% |
AZN Total Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -7.0% | +40.4% | -8.7% | +10.4% |
| 5 y | 5 years | -7.0% | +57.0% | -8.7% | +73.8% |
| alltime | all time | -7.0% | +6190.6% | -8.7% |
AstraZeneca Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $31.56 B(-5.9%) |
| June 2024 | - | $33.53 B(-2.9%) |
| Mar 2024 | - | $34.55 B(+20.7%) |
| Dec 2023 | $28.62 B(-2.1%) | $28.62 B(+0.2%) |
| Sept 2023 | - | $28.58 B(-4.2%) |
| June 2023 | - | $29.84 B(-5.3%) |
| Mar 2023 | - | $31.50 B(+7.8%) |
| Dec 2022 | $29.23 B(-5.0%) | $29.23 B(-0.2%) |
| Sept 2022 | - | $29.30 B(-0.8%) |
| June 2022 | - | $29.53 B(-5.1%) |
| Mar 2022 | - | $31.10 B(+1.0%) |
| Dec 2021 | $30.78 B(+51.0%) | $30.78 B(-3.5%) |
| Sept 2021 | - | $31.91 B(+16.1%) |
| June 2021 | - | $27.50 B(+36.6%) |
| Mar 2021 | - | $20.13 B(-1.2%) |
| Dec 2020 | $20.38 B(+11.8%) | $20.38 B(-8.8%) |
| Sept 2020 | - | $22.34 B(+13.1%) |
| June 2020 | - | $19.75 B(+6.3%) |
| Mar 2020 | - | $18.58 B(+1.9%) |
| Dec 2019 | $18.23 B(-4.6%) | $18.23 B(+0.4%) |
| Sept 2019 | - | $18.16 B(-7.8%) |
| June 2019 | - | $19.70 B(-8.7%) |
| Mar 2019 | - | $21.58 B(+12.9%) |
| Dec 2018 | $19.11 B(+7.3%) | $19.11 B(-8.6%) |
| Sept 2018 | - | $20.91 B(+6.3%) |
| June 2018 | - | $19.67 B(-0.9%) |
| Mar 2018 | - | $19.85 B(+11.5%) |
| Dec 2017 | $17.81 B(+5.9%) | $17.81 B(-0.3%) |
| Sept 2017 | - | $17.85 B(-9.5%) |
| June 2017 | - | $19.73 B(+13.3%) |
| Mar 2017 | - | $17.40 B(+3.5%) |
| Dec 2016 | $16.81 B(+11.7%) | $16.81 B(-4.9%) |
| Sept 2016 | - | $17.68 B(+0.6%) |
| June 2016 | - | $17.58 B(+7.8%) |
| Mar 2016 | - | $16.31 B(+8.4%) |
| Dec 2015 | $15.05 B(+38.8%) | $15.05 B(+37.5%) |
| Sept 2015 | - | $10.95 B(-0.6%) |
| June 2015 | - | $11.01 B(+4.2%) |
| Mar 2015 | - | $10.57 B(-2.5%) |
| Dec 2014 | $10.84 B(+4.5%) | $10.84 B(+9.2%) |
| Sept 2014 | - | $9.93 B(-1.5%) |
| June 2014 | - | $10.07 B(-2.6%) |
| Mar 2014 | - | $10.34 B(-0.3%) |
| Dec 2013 | $10.38 B(+0.6%) | $10.38 B(+1.0%) |
| Sept 2013 | - | $10.28 B(-1.1%) |
| June 2013 | - | $10.39 B(+1.7%) |
| Mar 2013 | - | $10.21 B(-1.0%) |
| Dec 2012 | $10.31 B(+10.5%) | $10.31 B(-5.5%) |
| Sept 2012 | - | $10.91 B(+17.1%) |
| June 2012 | - | $9.32 B(-0.7%) |
| Mar 2012 | - | $9.38 B(+0.6%) |
| Dec 2011 | $9.33 B(+1.1%) | $9.33 B(-1.3%) |
| Sept 2011 | - | $9.45 B(-1.4%) |
| June 2011 | - | $9.58 B(-3.9%) |
| Mar 2011 | - | $9.97 B(+8.1%) |
| Dec 2010 | $9.22 B(-16.6%) | $9.22 B(-15.4%) |
| Sept 2010 | - | $10.91 B(+631.9%) |
| June 2010 | - | $1.49 B(-85.9%) |
| Mar 2010 | - | $10.56 B(-4.5%) |
| Dec 2009 | $11.06 B(+868.7%) | $11.06 B(-3.8%) |
| Sept 2009 | - | $11.50 B(-2.7%) |
| June 2009 | - | $11.82 B(+0.5%) |
| Mar 2009 | - | $11.77 B(+930.4%) |
| Dec 2008 | $1.14 B | $1.14 B(-91.5%) |
| Sept 2008 | - | $13.37 B(-10.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2008 | - | $14.87 B(-0.9%) |
| Mar 2008 | - | $15.00 B(-1.0%) |
| Dec 2007 | $15.16 B(+1139.2%) | $15.16 B(+5.3%) |
| Sept 2007 | - | $14.40 B(-6.5%) |
| June 2007 | - | $15.40 B(+1243.7%) |
| Mar 2007 | - | $1.15 B(-6.3%) |
| Dec 2006 | $1.22 B(+1.8%) | $1.22 B(+1.7%) |
| Sept 2006 | - | $1.20 B(+6.3%) |
| June 2006 | - | $1.13 B(-7.5%) |
| Mar 2006 | - | $1.22 B(+1.8%) |
| Dec 2005 | $1.20 B(-5.4%) | $1.20 B(-3.5%) |
| Sept 2005 | - | $1.24 B(-5.3%) |
| June 2005 | - | $1.31 B(+9.3%) |
| Mar 2005 | - | $1.20 B(-5.4%) |
| Dec 2004 | $1.27 B(+178.9%) | $1.27 B(+0.3%) |
| Sept 2004 | - | $1.26 B(+5.5%) |
| June 2004 | - | $1.20 B(+218.0%) |
| Mar 2004 | - | $377.00 M(-17.1%) |
| Dec 2003 | $455.00 M(-46.1%) | $455.00 M(>+9900.0%) |
| Sept 2003 | - | $0.00(-100.0%) |
| June 2003 | - | $379.05 M(>+9900.0%) |
| Mar 2003 | - | $0.00(-100.0%) |
| Dec 2002 | $844.00 M(-11.7%) | $844.00 M(>+9900.0%) |
| Sept 2002 | - | $0.00(-100.0%) |
| June 2002 | - | $817.63 M(>+9900.0%) |
| Mar 2002 | - | $0.00(-100.0%) |
| Dec 2001 | $956.00 M(+13.1%) | $956.00 M(>+9900.0%) |
| Sept 2001 | - | $0.00(-100.0%) |
| June 2001 | - | $907.66 M(>+9900.0%) |
| Mar 2001 | - | $0.00(-100.0%) |
| Dec 2000 | $845.38 M(-24.5%) | $845.38 M(>+9900.0%) |
| Sept 2000 | - | $0.00(-100.0%) |
| June 2000 | - | $1.19 B(>+9900.0%) |
| Mar 2000 | - | $0.00(-100.0%) |
| Dec 1999 | $1.12 B(-1.7%) | $1.12 B(-0.4%) |
| Sept 1999 | - | $1.12 B(-21.3%) |
| June 1999 | - | $1.43 B(>+9900.0%) |
| Mar 1999 | - | $0.00(-100.0%) |
| Dec 1998 | $1.14 B(-2.9%) | $1.14 B(>+9900.0%) |
| Sept 1998 | - | $0.00(-100.0%) |
| June 1998 | - | $1.34 B(>+9900.0%) |
| Mar 1998 | - | $0.00(-100.0%) |
| Dec 1997 | $1.17 B(-5.7%) | $1.17 B(>+9900.0%) |
| Sept 1997 | - | $0.00(0.0%) |
| June 1997 | - | $0.00(0.0%) |
| Mar 1997 | - | $0.00(-100.0%) |
| Dec 1996 | $1.24 B(-2.0%) | $1.24 B(>+9900.0%) |
| Sept 1996 | - | $0.00(0.0%) |
| June 1996 | - | $0.00(0.0%) |
| Mar 1996 | - | $0.00(-100.0%) |
| Dec 1995 | $1.27 B(+8.5%) | $1.27 B(>+9900.0%) |
| Sept 1995 | - | $0.00(-100.0%) |
| June 1995 | - | $1.36 B(>+9900.0%) |
| Mar 1995 | - | $0.00(-100.0%) |
| Dec 1994 | $1.17 B(-36.6%) | $1.17 B(>+9900.0%) |
| Sept 1994 | - | $0.00(0.0%) |
| June 1994 | - | $0.00(0.0%) |
| Mar 1994 | - | $0.00(-100.0%) |
| Dec 1993 | $1.84 B(-46.8%) | $1.84 B(>+9900.0%) |
| Sept 1993 | - | $0.00(0.0%) |
| June 1993 | - | $0.00(0.0%) |
| Mar 1993 | - | $0.00 |
| Dec 1992 | $3.47 B(+1.2%) | - |
| Dec 1991 | $3.43 B(-1.5%) | - |
| Dec 1990 | $3.48 B | - |
FAQ
- What is AstraZeneca annual total debt?
- What is the all time high annual total debt for AstraZeneca?
- What is AstraZeneca annual total debt year-on-year change?
- What is AstraZeneca quarterly total debt?
- What is the all time high quarterly total debt for AstraZeneca?
- What is AstraZeneca quarterly total debt year-on-year change?
What is AstraZeneca annual total debt?
The current annual total debt of AZN is $28.62 B
What is the all time high annual total debt for AstraZeneca?
AstraZeneca all-time high annual total debt is $30.78 B
What is AstraZeneca annual total debt year-on-year change?
Over the past year, AZN annual total debt has changed by -$610.00 M (-2.09%)
What is AstraZeneca quarterly total debt?
The current quarterly total debt of AZN is $31.56 B
What is the all time high quarterly total debt for AstraZeneca?
AstraZeneca all-time high quarterly total debt is $34.55 B
What is AstraZeneca quarterly total debt year-on-year change?
Over the past year, AZN quarterly total debt has changed by +$2.99 B (+10.45%)